Sailong Pharmaceutical Group announcement, the company's stocks experienced abnormal fluctuations with a cumulative deviation of 21.31% in the closing prices for two consecutive trading days on September 9th and September 10th, 2024. The company has verified that there is no significant undisclosed information that should be disclosed. There have been no major changes in the company's recent operations and internal and external business environment. There are no significant undisclosed matters concerning the company, controlling shareholders, or actual controllers. The controlling shareholders and actual controllers have not engaged in any buying or selling of company stocks during the period of abnormal stock fluctuations.